News from Lifecore's Hyaluronan Division
Lifecore & Hyaluronan:
Lifecore manufactures medical grade hyaluronan (also known as hyaluronic acid or sodium hyaluronate) in a variety of molecular weights. Its broad range of medical applications include ophthalmology, orthopedics, veterinary medicine and drug delivery.
Here’s the latest news from the Hyaluronan Division of Lifecore Biomedical:
- 7/22/2009 - Lifecore announces their agreement with Hyalose to distribute Hyalose's Nano-HATM, Oligo-HATM, and Select-HATM
- 5/11/2009 - Lifecore announces commercial launch of CorgelTM BioHydrogel
- 3/21/2008 - SBT Acquistion Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
SBT Acquisition Inc., a wholly owned subsidiary of SBT Holdings Inc., which is wholly owned by Warburg Pincus Private Equity IX, L.P., has successfully completed the tender offer for all of the outstanding shares of common stock of Lifecore Biomedical, Inc. (Nasdaq: LCBM).
- 1/31/2008 - Lifecore Renews Manufacturing Agreement with Alcon
Lifecore Biomedical, Inc. announced today that it has renewed its manufacturing agreement with Alcon Pharmaceuticals, Ltd., a subsidiary of Alcon, Inc. (NYSE: ACL), the world's leading eye care company.
- 4/23/2007 - Announcement of Cleveland Clinic License Agreement
Lifecore Biomedical, Inc. announced today that it has entered into an exclusive license agreement and development agreement with Cleveland Clinic to develop and commercialize hyaluronan-based products and related applications.